Loading...
Dapagliflozin
India Pharmaceutical Trade Intelligence
Who Supplies Dapagliflozin to India from AUSTRALIA
India's dapagliflozin imports from AUSTRALIA total $31.6K across 16 shipments from 7 foreign suppliers. SAVI CLINICALS FZ LLC leads with $13.1K in import value; the top 5 suppliers together control 97.2% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for dapagliflozin — a diversified sourcing base with multiple active suppliers from AUSTRALIA.
Top foreign suppliers (AUSTRALIA) — Ranked by import value
SAVI CLINICALS FZ LLC is the leading Dapagliflozin supplier from AUSTRALIA to India, with import value of $13.1K across 4 shipments. The top 5 suppliers — SAVI CLINICALS FZ LLC, PHARMACY WHOLESALERS PTY LTD, SEED PHARMA PTY LTD, New Life Medicals (USA), Inc., NEWLIFE MEDICALS USA INC — collectively account for 97.2% of total import value from this origin.
Top foreign suppliers (AUSTRALIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SAVI CLINICALS FZ LLC | $13.1K | 4 | 41.5% |
| 2 | PHARMACY WHOLESALERS PTY LTD | $6.6K | 1 | 21.0% |
| 3 | SEED PHARMA PTY LTD | $6.5K | 7 | 20.5% |
| 4 | New Life Medicals (USA), Inc. | $2.9K | 1 | 9.0% |
| 5 | NEWLIFE MEDICALS USA INC | $1.6K | 1 | 5.2% |
| 6 | SYNTRO HEALTH | $632 | 1 | 2.0% |
| 7 | PRO PHARMACEUTICALS GROUP PTY LTD | $238 | 1 | 0.8% |
Showing top 7 of 7 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from AUSTRALIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $13.1K | 4 | 41.5% |
| 2 | IND SWIFT LIMITED | $6.6K | 1 | 21.0% |
| 3 | INVENTIA HEALTHCARE LIMITED | $6.5K | 7 | 20.5% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED | $2.9K | 1 | 9.0% |
| 5 | LUPIN LIMITED | $1.6K | 1 | 5.2% |
| 6 | THE VOLUNTARY HEALTH SERVICES | $632 | 1 | 2.0% |
| 7 | DR.REDDY'S LABORATORIES LTD | $238 | 1 | 0.8% |
Import Statistics
- Import Value
- $31.6K
- Shipments
- 16
- Foreign Suppliers
- 7
- Indian Buyers
- 7
- Avg. Shipment
- $2.0K
Other Dapagliflozin Import Origins
Related Analysis
Frequently Asked Questions — Dapagliflozin Imports from AUSTRALIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Dapagliflozin suppliers from AUSTRALIA to India?
The top Dapagliflozin suppliers from AUSTRALIA to India include SAVI CLINICALS FZ LLC, PHARMACY WHOLESALERS PTY LTD, SEED PHARMA PTY LTD. The leading supplier is SAVI CLINICALS FZ LLC with import value of $13.1K USD across 4 shipments. India imported Dapagliflozin worth $31.6K USD from AUSTRALIA in total across 16 shipments.
QHow much Dapagliflozin does India import from AUSTRALIA?
India imported Dapagliflozin worth $31.6K USD from AUSTRALIA across 16 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Dapagliflozin from AUSTRALIA?
The main Indian buyers of Dapagliflozin sourced from AUSTRALIA include MSN LABORATORIES PRIVATE LIMITED, IND SWIFT LIMITED, INVENTIA HEALTHCARE LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $13.1K in imports across 4 shipments.
QWhat is the total value of Dapagliflozin imports from AUSTRALIA to India?
The total value of Dapagliflozin imports from AUSTRALIA to India is $31.6K USD, across 16 shipments and 7 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: AUSTRALIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Dapagliflozin.
- 2.Supplier/Buyer Matching: 7 foreign suppliers from AUSTRALIA and 7 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $31.6K aggregated from 16 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
7 suppliers, 7 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists